Sunitinib-induced cardiac hypertrophy and the endothelin axis

Anti-angiogenics drugs in clinical use for cancer treatment induce cardiotoxic side effects. The endothelin axis is involved in hypertension and cardiac remodelling, and addition of an endothelin receptor antagonist to the anti-angiogenic sunitinib was shown to reduce cardiotoxicity of sunitinib in...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Theranostics
Päätekijät: Sourdon, Joevin, Facchin, Caterina, Certain, Anaïs, Viel, Thomas, Robin, Blaise, Lager, Franck, Marchiol, Carmen, Balvay, Daniel, Yoganathan, Thulaciga, Favier, Judith, Tharaux, Pierre-Louis, Dhaun, Neeraj, Renault, Gilles, Tavitian, Bertrand
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Ivyspring International Publisher 2021
Aiheet:
Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7914356/
https://ncbi.nlm.nih.gov/pubmed/33664864
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.49837
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia